))
FORECAST Trial: Interview with Dr. Campbell Rogers
Manage episode 363469228 series 3476484
Indhold leveret af SCCT: Society of Cardiovascular Computed Tomography. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af SCCT: Society of Cardiovascular Computed Tomography eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Alastair and Praveen are joined by Dr. Campbell Rogers, CMO and executive VP at HeartFlow, to discuss the recently-published FORECAST trial. What are the economic and clinical outcomes of selective FFRct use in stable chest pain? Tune in and enjoy!
54 episoder
Del
